Results 121 to 130 of about 9,613,208 (373)

Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma

open access: yesCase Reports in Endocrinology, 2016
Objective. Thyroid disease has been reported among the endocrinopathies that can occur after treatment with ipilimumab. Graves' disease, however, has been rarely reported with this medication.
Umal Azmat   +4 more
semanticscholar   +1 more source

Toward the 3rd Generation of Smart Farming: Materials, Devices, and Systems for E‐Plant Technologies

open access: yesAdvanced Functional Materials, EarlyView.
This review explores the latest developments in e‐plant technologies, which are revolutionizing smart farming by enabling real‐time monitoring of plant and environmental conditions. It covers the design, applications, and systems of e‐plant devices, detailing how they integrate data analytics to optimize agricultural practices, enhance crop yields, and
Daegun Kim   +5 more
wiley   +1 more source

Current concepts in Graves’ disease

open access: yesTherapeutic Advances in Endocrinology and Metabolism, 2011
Graves’ disease is the most common cause of hyperthyroidism in the developed world. It is caused by an immune defect in genetically susceptible individuals in whom the production of unique antibodies results in thyroid hormone excess and glandular ...
Christian M. Girgis   +2 more
doaj   +1 more source

Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease.

open access: yesJAMA ophthalmology, 2015
IMPORTANCE Thyroid-associated ophthalmopathy (TAO) is a common and debilitating manifestation of Graves disease (GD). Presently little is known about factors that may increase the risk of developing TAO among patients with GD.
J. Stein   +7 more
semanticscholar   +1 more source

Exacerbation of erythropoietic protoporphyria by hyperthyroidism [PDF]

open access: yes, 2018
Erythropoietic protoporphyria (EPP) is a hereditary disorder caused by deficiency of ferrochelatase, the last enzyme in the heme biosynthetic pathway. The majority of EPP patients present with a clinical symptom of painful phototoxicity.
Haldemann, Andreas   +2 more
core  

Wafer‐Scale Integration of α‐quartz Thin Films toward Super High Frequency Piezoelectric bioNEMS for Chikungunya Virus Detection

open access: yesAdvanced Functional Materials, EarlyView.
Epitaxial piezoelectric α‐quartz/Si BioNEMS sensors, made using soft chemistry, effectively detect the Chikungunya virus. They have a mass sensitivity of 205 pg Hz−1 in liquid and can detect the virus at a limit of 9 ng mL−1. This development enables high‐frequency mass devices for point‐of‐care testing in healthcare and other electronic applications ...
Raissa Rathar   +12 more
wiley   +1 more source

Increased incidence of Graves’ disease during the COVID-19 pandemic in children and adolescents in the United States

open access: yesFrontiers in Endocrinology
IntroductionReports in adults indicate that Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) infection and vaccination trigger the expression of autoimmune disease such as Graves’ disease, but the incidence of new onset Graves’ disease and ...
Naama Pollack-Schreiber   +3 more
doaj   +1 more source

Case of Graves’ disease recovery

open access: yesJournal of Clinical and Translational Endocrinology Case Reports, 2023
The pathogenesis of Graves’ disease (GD) is considered to be an etiologically multifactorial process of external influence on specific genes that are susceptible to the autoimmune reaction stimulating thyroid hormonogenesis.
Andrey Valerievich Ushakov
doaj  

A Genomic Point Mutation in the Extracellular Domain of the Thyrotropin Receptor in Patients with Graves’ Ophthalmopathy [PDF]

open access: yes, 1994
Orbital and pretibial fibroblasts are targets of autoimmune attack in Graves' ophthalmopathy (GO) and pretibial dermopathy (PTD). The fibroblast autoantigen involved in these peripheral manifestations of Graves' disease and the reason for the association
Bahn, Rebecca S.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy